What a Manufacturing Execution System is
A Manufacturing Execution System (MES) is a software platform that manages, monitors and documents manufacturing operations in real time on the production floor. It sits between the enterprise resource planning (ERP) system — which handles business planning, inventory and finance — and the process control systems and equipment on the shop floor. Its primary function is to translate production orders into executed, documented manufacturing operations, capturing data at every step.
In pharmaceutical manufacturing, MES platforms have become the central technology for managing batch documentation, process execution, material tracking and production visibility. They are the system of record for the manufacturing process — the digital equivalent of the batch manufacturing record, but with real-time guidance, enforcement and data capture built in.
For cannabis manufacturers operating at or targeting EU GMP standards, MES technology is relevant at a certain scale and complexity of operations. Small operations may find that well-designed paper batch records are sufficient. As batch volumes grow, product complexity increases, and regulatory scrutiny intensifies, the operational and compliance advantages of MES become increasingly compelling.
Core MES functions in pharmaceutical manufacturing
Modern pharmaceutical MES platforms typically provide the following core functions:
- Electronic batch records (EBR): Digital master batch records guide operators through each manufacturing step, capturing entries, electronic signatures and timestamps. The EBR is the primary output of the MES for each batch.
- Recipe and master batch record management: MES platforms store approved master batch records and recipes in controlled, versioned libraries. Changes to master batch records follow a defined change control process within the system.
- Material management: The MES tracks materials from receipt through use in production, ensuring the correct material, at the correct version, is used in each batch. This includes confirmation of material status (released, quarantined, rejected) and prevention of use of unreleased materials.
- Equipment management: The MES tracks equipment status, cleaning status, maintenance schedules and qualification status. It can prevent use of equipment that is due for cleaning, maintenance or requalification.
- Work-in-progress tracking: Real-time visibility of where each batch is in the manufacturing process, what operations have been completed, and what is pending.
- Label management: Generation and tracking of GMP-compliant labels for materials, intermediates and finished products, with version control and audit trail.
- Environmental and process data integration: Integration with process control systems, environmental monitoring systems and laboratory instruments to automatically capture critical process data without manual transcription.
- Deviation and exception management: Capture of process exceptions, automatic flagging of out-of-specification results, and initiation of deviation records within the quality system.
- Reporting and batch record review: Generation of completed electronic batch records for QA review and batch release, with full audit trail of all entries and any modifications.
MES and GMP compliance
MES platforms support GMP compliance in several important ways that are difficult or impossible to replicate with paper-based systems at scale.
Process sequence enforcement: The MES can prevent operators from proceeding to a subsequent manufacturing step before all required entries for the current step have been completed and signed. This eliminates the risk of steps being missed or completed out of sequence.
Automatic audit trail: Every entry, modification and electronic signature in the MES is captured in an automatically generated, time-stamped audit trail. This provides complete traceability of all manufacturing data in a form that meets EU GMP Annex 11 requirements and cannot be modified without detection.
Right-first-time guidance: Structured step-by-step guidance in the EBR reduces the risk of human error. Operators are guided to the correct procedure, prompted for required entries, and alerted to values outside defined limits before proceeding.
Data integrity: By capturing data electronically at source — through direct equipment integration, barcode scanning or structured data entry — MES platforms reduce the opportunities for transcription errors, retrospective completion and other data integrity risks associated with paper-based documentation.
Batch record completeness: The MES can enforce that all required fields are completed before the batch record is closed for QA review, reducing the frequency of batch record queries and re-work during the release process.
MES and electronic batch records
The relationship between MES and EBR is straightforward: the EBR is one of the primary outputs of the MES. When a batch is manufactured using an MES, the system generates a complete electronic batch record documenting every step, material, measurement and signature in the manufacturing process. This EBR is then reviewed by QA and forms the basis for batch certification and release.
However, not all MES implementations include a full EBR module. Some MES platforms focus on production scheduling, equipment management and work-in-progress tracking, with batch documentation handled separately. When evaluating MES options, cannabis manufacturers should be clear about which functions they require — a full EBR capability, or MES functions complementing an existing or separate EBR system.
Annex 11 and Computer System Validation
An MES is a computerised system used in GMP manufacturing, and is therefore within scope of EU GMP Annex 11. This means the MES must be validated through a formal Computer System Validation (CSV) programme before it is used to create, process or store GMP data.
The CSV programme for an MES is typically substantial — MES platforms are complex systems with many functions, and validation must cover each function used in GMP operations. A phased implementation and validation approach — validating core functions first and extending to additional modules in subsequent phases — is a practical approach for cannabis manufacturers with limited validation resource.
Key CSV considerations for MES implementation include: supplier qualification (assessing the MES supplier's quality systems and regulatory track record), use of supplier-provided validation packages (most pharmaceutical MES suppliers provide validation documentation that can be leveraged, reducing the total validation effort), integration qualification (validating each interface between the MES and connected systems), and user acceptance testing (verifying that the system performs as required in the real production environment).
MES in cannabis manufacturing — the current reality
MES adoption in the cannabis sector is at an early stage. Most cannabis manufacturing operations — including many that have obtained EU GMP certification — continue to use paper batch records or basic digital documentation tools rather than full pharmaceutical MES platforms. This is understandable given the cost and implementation complexity of MES, but it reflects a gap between the current state of the sector and the documentation and data integrity standards that are increasingly expected.
The most common starting point for cannabis manufacturers moving from paper toward digital manufacturing documentation is an electronic batch record system — either a standalone EBR platform or a quality management system (QMS) with EBR capability. This is a more accessible entry point than a full MES and can deliver significant data integrity improvements at lower cost and complexity.
Full MES implementation becomes compelling for cannabis manufacturers when: batch volumes are significant and batch record management is creating a production bottleneck; multiple product types with complex recipes require reliable recipe management and version control; integration with laboratory systems, environmental monitoring and equipment is needed to reduce manual data entry; or where commercial supply relationships require demonstrated digital manufacturing quality systems.
Selecting an MES platform
Selecting an MES for a cannabis manufacturing operation requires a structured approach. The starting point is a User Requirements Specification (URS) that clearly defines what the system must do — the functional requirements, the integration requirements, the reporting requirements and the compliance requirements. The URS drives both the selection process and the subsequent validation programme.
Key evaluation criteria include: pharmaceutical GMP compliance (the system must be designed for pharmaceutical GMP environments, with Annex 11-compliant audit trail, electronic signatures and access controls as standard); scalability (the system should be capable of growing with the operation without requiring replacement); supplier regulatory track record (the supplier should have a track record of supporting pharmaceutical GMP customers through regulatory inspections); implementation support (MES implementation is complex and typically requires both the supplier's technical support and pharmaceutical consulting expertise); and total cost of ownership (including implementation, training, validation, ongoing support and upgrades).
Common mistakes
- Selecting an MES before defining requirements: System selection before the URS is complete leads to selecting a system that meets the supplier's strengths rather than the operation's needs.
- Underestimating implementation complexity: MES implementation in a pharmaceutical manufacturing environment is a major project. Resource and timeline estimates based on IT projects in other sectors are typically inadequate.
- Inadequate master batch record design: An MES is only as good as the master batch records it executes. Poorly designed master records produce poorly structured electronic batch records.
- Skipping or rushing CSV: Validation shortcuts create regulatory risk and, more practically, mean the system may not perform reliably in production. CSV is an investment, not a bureaucratic overhead.
- Insufficient training for operators and QA: Both production teams and QA reviewers need comprehensive training. QA training on reviewing and approving electronic batch records in an MES environment is frequently overlooked.
Frequently asked questions
Does a small cannabis manufacturer need an MES?
No. MES is one option on a spectrum of manufacturing documentation approaches. Well-designed, GMP-compliant paper batch records are acceptable for small operations. The decision to invest in MES should be based on operational scale, complexity and the specific data integrity and efficiency challenges being experienced — not on a generic assumption that pharmaceutical manufacturing requires MES.
What is the difference between an MES and a QMS?
A Quality Management System (QMS) manages quality processes — deviations, CAPAs, change control, supplier management, training, audits. An MES manages manufacturing execution — batch records, material tracking, equipment management, production scheduling. The two systems complement each other and in many pharmaceutical operations are integrated, but they serve different primary functions. Some platforms offer combined QMS/MES functionality.
Key takeaways
- An MES is a software platform that manages manufacturing execution, with electronic batch records as its primary GMP output.
- MES supports GMP compliance through process sequence enforcement, automatic audit trail, right-first-time guidance and data integrity controls.
- Any pharmaceutical MES is within scope of EU GMP Annex 11 and must be validated through a CSV programme.
- Most cannabis manufacturers currently use paper batch records or basic digital tools. Full MES adoption is growing as operations mature.
- MES selection should begin with a User Requirements Specification and use pharmaceutical GMP compliance as a primary selection criterion.
References
- EU GMP Annex 11 — Computerised Systems
- ISPE GAMP 5 — A Risk-Based Approach to Compliant GxP Computerised Systems (2nd Edition)
- EMA Reflection Paper on Expectations for Electronic Data Recording and Data Integrity (EMA/INS/GMP/413098/2019)
- PIC/S Guidance on Good Data and Record Management Practices (PI 041-1)
Related content
Electronic Batch Records in Cannabis Manufacturing Batch Manufacturing Records SOPs in Cannabis Manufacturing MES User Requirements Specification Template